AlzBiomarker
CBS vs Alzheimer's Disease: tau-p181 (CSF)
Meta-analysis of ten studies showed that levels of tau-p181 in the cerebrospinal fluid of people with corticobasal syndrome are about half those in people with Alzheimer's disease (effect size = 0.513, p <0.0001). For comparison, the level of CSF tau-p181 in control subjects is also about half that of AD patients.
Loading data...